These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17900853)

  • 1. Transdermal buprenorphine may be effective in the treatment of pruritus in primary biliary cirrhosis.
    Reddy L; Krajnik M; Zylicz Z
    J Pain Symptom Manage; 2007 Nov; 34(5):455-6. PubMed ID: 17900853
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus.
    Marinangeli F; Guetti C; Angeletti C; Bonetti C; Paladini A; Piroli A; Varrassi G
    J Pain Symptom Manage; 2009 Oct; 38(4):e5-8. PubMed ID: 19699606
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal buprenorphine (Butrans) for chronic pain.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old.
    Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM
    J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal mucositis pain treatment with transdermal buprenorphine in patients after allogeneic stem cell transplantation.
    Vokurka S; Skardova J; Karas M; Kostkova J; Steinerova K; Koza V; Bystricka E
    J Pain Symptom Manage; 2010 Jun; 39(6):e4-6. PubMed ID: 20538178
    [No Abstract]   [Full Text] [Related]  

  • 7. Pruritus and fatigue in primary biliary cirrhosis.
    Bergasa NV; Mehlman JK; Jones EA
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):643-55. PubMed ID: 10976020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal buprenorphine and silent acute coronary syndrome].
    Vidal MA; Calderón E; Pernia A; Calderón-Pla E; Torres LM
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):58-9. PubMed ID: 16475644
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland.
    Przeklasa-Muszynska A; Dobrogowski J
    Curr Med Res Opin; 2011 Jun; 27(6):1109-17. PubMed ID: 21456888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis.
    Aguilar-Bernier M; Bassas-Vila J; Sanz-Munoz C; Miranda-Romero A
    Br J Dermatol; 2005 Apr; 152(4):808-9. PubMed ID: 15840123
    [No Abstract]   [Full Text] [Related]  

  • 11. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.
    Louis F
    Int J Clin Pract; 2006 Oct; 60(10):1330-4. PubMed ID: 16981980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal buprenorphine for central neuropathic pain: clinical reports.
    Guetti C; Angeletti C; Marinangeli F; Ciccozzi A; Baldascino G; Paladini A; Varrassi G
    Pain Pract; 2011; 11(5):446-52. PubMed ID: 21199314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus in primary biliary cirrhosis: pathogenesis and therapy.
    Bergasa NV
    Clin Liver Dis; 2008 May; 12(2):385-406; x. PubMed ID: 18456187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron.
    Di Martino M; Galanti B; Nardiello S
    Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475
    [No Abstract]   [Full Text] [Related]  

  • 16. Transdermal buprenorphine in children with cancer-related pain.
    Attinà G; Ruggiero A; Maurizi P; Arlotta A; Chiaretti A; Riccardi R
    Pediatr Blood Cancer; 2009 Jan; 52(1):125-7. PubMed ID: 18802942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal buprenorphine intoxication.
    Magdalan J; Merwid-Lad A
    Clin Toxicol (Phila); 2008 Nov; 46(9):915-6. PubMed ID: 18608275
    [No Abstract]   [Full Text] [Related]  

  • 18. Buprenorphine and hepatic pruritus.
    Juby LD; Wong VS; Losowsky MS
    Br J Clin Pract; 1994; 48(6):331. PubMed ID: 7848799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report.
    Zylicz Z; Stork N; Krajnik M
    J Pain Symptom Manage; 2005 Jan; 29(1):100-3. PubMed ID: 15652443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the equipotency calculation for transdermal buprenorphine: four case studies.
    Likar R; Krainer B; Sittl R
    Int J Clin Pract; 2008 Jan; 62(1):152-6. PubMed ID: 18173815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.